| Literature DB >> 35463637 |
Sujin Oh1, Soo Kyung Nam1, Ho Eun Chang2, Kyoung Un Park1,3.
Abstract
Vancomycin-resistant enterococci (VRE) are nosocomial pathogens with genetic plasticity and widespread antimicrobial resistance (AMR). To prevent the spread of VRE in the hospital setting, molecular epidemiological approaches such as pulsed-field gel electrophoresis and multilocus sequence typing have been implemented for pathogen outbreak surveillance. However, due to the insufficient discriminatory power of these methods, whole-genome sequencing (WGS), which enables high-resolution analysis of entire genomic sequences, is being used increasingly. Herein, we performed WGS of VRE using both short-read next-generation sequencing (SR-NGS) and long-read next-generation sequencing (LR-NGS). Since standardized workflows and pipelines for WGS-based bacterial epidemiology are lacking, we established three-step pipelines for SR- and LR-NGS, as a standardized WGS-based approach for strain typing and AMR profiling. For strain typing, we analyzed single-nucleotide polymorphisms (SNPs) of VRE isolates and constructed SNP-based maximum-likelihood phylogenies. The phylogenetic trees constructed using short and long reads showed good correspondence. Still, SR-NGS exhibited higher sensitivity for detecting nucleotide substitutions of bacterial sequences. During AMR profiling, we examined AMR genes and resistance-conferring mutations. We also assessed the concordance between genotypic and phenotypic resistance, which was generally better for LR-NGS than SR-NGS. Further validation of our pipelines based on outbreak cases is necessary to ensure the overall performance of pipelines.Entities:
Keywords: antimicrobial resistance; long-read next-generation sequencing; molecular epidemiology; short-read next-generation sequencing; strain typing; vancomycin-resistant enterococci
Mesh:
Substances:
Year: 2022 PMID: 35463637 PMCID: PMC9019564 DOI: 10.3389/fcimb.2022.857801
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Quality control results of FastQC for the raw short-read next-generation sequencing data.
| Isolate | Reads | Mean length | Mean Q | %Q30 | GC% |
|---|---|---|---|---|---|
| EF01 | 193500 | 138.17 | 34.22 | 93.03 | 36 |
| EF02 | 67044 | 144.39 | 34.33 | 93.92 | 37 |
| EF03 | 531506 | 142.92 | 34.11 | 92.36 | 36 |
| EF04 | 273490 | 145.26 | 34.06 | 92.04 | 36 |
| EF05 | 91784 | 141.88 | 34.23 | 93.22 | 36 |
| EF06 | 73214 | 141.94 | 34.32 | 94.23 | 36 |
| EF07 | 440134 | 146.56 | 34.11 | 92.37 | 35 |
| EF08 | 302150 | 146.69 | 34.09 | 92.33 | 36 |
| EF09 | 123002 | 144.29 | 34.23 | 93.50 | 35 |
| EF10 | 79648 | 143.82 | 34.30 | 93.66 | 36 |
| EF11 | 180582 | 145.15 | 34.33 | 94.18 | 36 |
| EF12 | 23474 | 141.69 | 34.36 | 94.29 | 36 |
| EF13 | 140412 | 138.83 | 34.37 | 94.31 | 33 |
| EF14 | 53982 | 135.78 | 34.19 | 93.17 | 36 |
| EF15 | 34600 | 139.05 | 34.43 | 94.70 | 36 |
| EF16 | 420790 | 143.95 | 34.10 | 92.12 | 35 |
| EF17 | 239628 | 140.83 | 34.20 | 93.01 | 36 |
| EF18 | 244838 | 142.62 | 34.37 | 94.57 | 50 |
| EF19 | 566650 | 141.53 | 34.18 | 92.94 | 36 |
| EF20 | 433036 | 137.86 | 34.28 | 93.29 | 36 |
| EF21 | 281094 | 140.26 | 34.01 | 91.85 | 44 |
| EF22 | 119860 | 142.58 | 34.37 | 93.99 | 38 |
| EF23 | 234646 | 146.12 | 34.00 | 91.66 | 42 |
| Minimum | 23474 | 135.78 | 34.00 | 91.66 | 33 |
| Maximum | 566650 | 146.69 | 34.43 | 94.70 | 50 |
| Average | 223872 | 142.27 | 34.23 | 93.25 | 37.09 |
Q, quality score; %Q30, percentage of reads with a quality score > 30.
Quality control results of EPI2ME for the raw long-read next-generation sequencing data.
| Isolate | Reads | Mean length | Bases | Mean Q | %Q | ||
|---|---|---|---|---|---|---|---|
| %Q7 | %Q9 | %Q12 | |||||
| EF01 | 121786 | 828.53 | 100903788 | 8.42 | 100.00 | 22.92 | 0.27 |
| EF02 | 47108 | 838.77 | 39512611 | 8.42 | 100.00 | 22.10 | 0.22 |
| EF03 | 114267 | 834.69 | 95377335 | 8.47 | 100.00 | 24.47 | 0.31 |
| EF04 | 16015 | 905.70 | 14504865 | 8.38 | 100.00 | 21.12 | 0.18 |
| EF05 | 18121 | 821.51 | 14886591 | 8.27 | 100.00 | 17.55 | 0.14 |
| EF06 | 43279 | 756.26 | 32729984 | 8.35 | 100.00 | 19.84 | 0.15 |
| EF07 | 16391 | 909.97 | 14915270 | 8.52 | 100.00 | 27.53 | 0.30 |
| EF08 | 43191 | 939.54 | 40579505 | 8.45 | 100.00 | 23.76 | 0.24 |
| EF09 | 81437 | 896.46 | 73004798 | 8.40 | 100.00 | 22.14 | 0.20 |
| EF10 | 60704 | 892.42 | 54173505 | 8.34 | 100.00 | 19.63 | 0.17 |
| EF11 | 125774 | 910.26 | 114487045 | 8.47 | 100.00 | 23.98 | 0.30 |
| EF12 | 24779 | 771.36 | 19113414 | 8.28 | 100.00 | 17.21 | 0.20 |
| EF13 | 26114 | 842.03 | 21988669 | 8.72 | 100.00 | 33.20 | 0.83 |
| EF14 | 44000 | 767.00 | 33748184 | 8.57 | 100.00 | 27.31 | 0.41 |
| EF15 | 24000 | 757.86 | 18188524 | 8.52 | 100.00 | 25.14 | 0.54 |
| EF16 | 159372 | 801.09 | 127671311 | 8.67 | 100.00 | 31.78 | 0.67 |
| EF17 | 52000 | 841.40 | 43752949 | 8.51 | 100.00 | 25.60 | 0.47 |
| EF21 | 370750 | 797.24 | 295576153 | 8.57 | 100.00 | 28.82 | 0.41 |
| EF22 | 48000 | 918.98 | 44111054 | 8.30 | 100.00 | 16.73 | 0.22 |
| EF23 | 172000 | 871.35 | 149872845 | 8.52 | 100.00 | 25.73 | 0.37 |
| Minimum | 16015 | 756.26 | 14504865 | 8.27 | 100.00 | 16.73 | 0.14 |
| Maximum | 370750 | 939.54 | 295576153 | 8.72 | 100.00 | 33.20 | 0.83 |
| Average | 80454 | 845.12 | 67454920 | 8.46 | 100.00 | 23.83 | 0.33 |
Q, quality score; %Q7, percentage of reads with a quality score > 7; %Q9, percentage of reads with a quality score > 9; %Q12, percentage of reads with a quality score > 12.
Figure 1Comparison of the numbers of single-nucleotide variants (SNVs) in vancomycin-resistant Enterococcus faecium isolates identified by short-read next-generation sequencing (SR-NGS) and long-read next-generation sequencing (LR-NGS).
Figure 2Single-nucleotide polymorphisms (SNPs) detected by whole-genome sequencing of vancomycin-resistant Enterococcus faecium (VREfm) isolates. (A) and (B) show the pairwise SNPs generated by short-read next-generation sequencing (SR-NGS) and long-read next-generation sequencing (LR-NGS). Each row and column in both heatmaps indicates a VREfm isolate, and the columns were clustered using the hierarchical clustering method. (C) The Wilcoxon rank-sum test showed that the number of SNPs detected differed significantly between the two methods (****: p-value < 0.0001).
Figure 3Comparison of the single-nucleotide polymorphism-based strain typing results of short-read next-generation sequencing (SR-NGS) and long-read next-generation sequencing (LR-NGS) for vancomycin-resistant Enterococcus faecium. (A) and (B) depict the maximum-likelihood phylogenies constructed using SR- and LR-NGS, respectively. The heatmaps on the right show the van gene clusters. (C) shows a tanglegram of the two phylogenetic trees.
Figure 4Concordance between the vancomycin resistance results obtained by short-read next-generation sequencing (SR-NGS), long-read next-generation sequencing (LR-NGS), and van gene specific polymerase chain reaction (PCR). The types of vancomycin resistance revealed by LR-NGS accorded with those confirmed by van gene specific PCR, while few vanA isolates were classified as vancomycin susceptible by SR-NGS.
Genes detected by short-read next-generation sequencing that confer antimicrobial resistance (AMR) to aminoglycoside.
| Isolate | AMR genes conferring aminoglycoside resistance | ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| EF01 |
|
|
|
|
|
| EF02 |
|
|
|
|
|
| EF03 |
|
|
|
|
|
| EF04 |
|
|
|
|
|
| EF05 |
|
|
|
|
|
| EF06 |
|
|
|
|
|
| EF07* |
|
|
|
|
|
| EF08 |
|
|
|
|
|
| EF09 |
|
|
|
|
|
| EF10 |
|
|
|
|
|
| EF11 |
|
|
|
|
|
| EF12 |
|
|
|
|
|
| EF13* |
|
|
|
|
|
| EF14 |
|
|
|
|
|
| EF15 |
|
|
|
|
|
| EF16* |
|
|
|
|
|
| EF17 |
|
|
|
|
|
| EF22 |
|
|
|
|
|
| EF23† |
|
|
|
|
|
|
| 10 | 2 | 4 | 6 | 5 |
|
| |||||
*Enterococcus faecalis.
†Enterococcus casseliflavus.
Genes detected by long-read next-generation sequencing that confer antimicrobial resistance (AMR) to aminoglycoside.
| Isolate | AMR genes conferring aminoglycoside resistance | ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| EF01 |
|
|
|
|
|
| EF02 |
|
|
|
|
|
| EF03 |
|
|
|
|
|
| EF04 |
|
|
|
|
|
| EF05 |
|
|
|
|
|
| EF06 |
|
|
|
|
|
| EF07* |
|
|
|
|
|
| EF08 |
|
|
|
|
|
| EF09 |
|
|
|
|
|
| EF10 |
|
|
|
|
|
| EF11 |
|
|
|
|
|
| EF12 |
|
|
|
|
|
| EF13* |
|
|
|
|
|
| EF14 |
|
|
|
|
|
| EF15 |
|
|
|
|
|
| EF16* |
|
|
|
|
|
| EF17 |
|
|
|
|
|
| EF22 |
|
|
|
|
|
| EF23† |
|
|
|
|
|
|
| 13 | 2 | 6 | 6 | 6 |
|
| |||||
*Enterococcus faecalis.
†Enterococcus casseliflavus.
Genes detected by short-read next-generation sequencing that confer antimicrobial resistance (AMR) to tetracycline and trimethoprim.
| Isolate | AMR genes conferring tetracycline resistance | AMR genes conferring trimethoprim resistance | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||||
| EF01 |
|
|
|
|
|
| ||||
| EF02 |
|
|
|
|
|
| ||||
| EF03 |
|
|
|
|
|
| ||||
| EF04 |
|
|
|
|
|
| ||||
| EF05 |
|
|
|
|
|
| ||||
| EF06 |
|
|
|
|
|
| ||||
| EF07* |
|
|
|
|
|
| ||||
| EF08 |
|
|
|
|
|
| ||||
| EF09 |
|
|
|
|
|
| ||||
| EF10 |
|
|
|
|
|
| ||||
| EF11 |
|
|
|
|
|
| ||||
| EF12 |
|
|
|
|
|
| ||||
| EF13* |
|
|
|
|
|
| ||||
| EF14 |
|
|
|
|
|
| ||||
| EF15 |
|
|
|
|
|
| ||||
| EF16* |
|
|
|
|
|
| ||||
| EF17 |
|
|
|
|
|
| ||||
| EF22 |
|
|
|
|
|
| ||||
| EF23† |
|
|
|
|
|
| ||||
|
| 4 | 1 | 0 | 0 | 0 | 4 | ||||
|
|
| |||||||||
*Enterococcus faecalis.
†Enterococcus casseliflavus.
Genes detected by long-read next-generation sequencing that confer antimicrobial resistance (AMR) to tetracycline and trimethoprim.
| Isolate | AMR genes conferring tetracycline resistance | AMR genes conferring trimethoprim resistance | ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| EF01 |
|
|
|
|
|
|
| EF02 |
|
|
|
|
|
|
| EF03 |
|
|
|
|
|
|
| EF04 |
|
|
|
|
|
|
| EF05 |
|
|
|
|
|
|
| EF06 |
|
|
|
|
|
|
| EF07* |
|
|
|
|
|
|
| EF08 |
|
|
|
|
|
|
| EF09 |
|
|
|
|
|
|
| EF10 |
|
|
|
|
|
|
| EF11 |
|
|
|
|
|
|
| EF12 |
|
|
|
|
|
|
| EF13* |
|
|
|
|
|
|
| EF14 |
|
|
|
|
|
|
| EF15 |
|
|
|
|
|
|
| EF16* |
|
|
|
|
|
|
| EF17 |
|
|
|
|
|
|
| EF22 |
|
|
|
|
|
|
| EF23† |
|
|
|
|
|
|
|
| 1 | 0 | 1 | 2 | 1 | 7 |
|
|
| |||||
*Enterococcus faecalis.
†Enterococcus casseliflavus.
Genes detected by short-read next-generation sequencing that confer antimicrobial resistance (AMR) to macrolide–lincosamide–streptogramin (MLS).
| Isolate | AMR genes conferring MLS Resistance | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| EF01 |
|
|
|
|
|
|
| EF02 |
|
|
|
|
|
|
| EF03 |
|
|
|
|
|
|
| EF04 |
|
|
|
|
|
|
| EF05 |
|
|
|
|
|
|
| EF06 |
|
|
|
|
|
|
| EF07* |
|
|
|
|
|
|
| EF08 |
|
|
|
|
|
|
| EF09 |
|
|
|
|
|
|
| EF10 |
|
|
|
|
|
|
| EF11 |
|
|
|
|
|
|
| EF12 |
|
|
|
|
|
|
| EF13* |
|
|
|
|
|
|
| EF14 |
|
|
|
|
|
|
| EF15 |
|
|
|
|
|
|
| EF16* |
|
|
|
|
|
|
| EF17 |
|
|
|
|
|
|
| EF22 |
|
|
|
|
|
|
| EF23† |
|
|
|
|
|
|
|
| 4 | 17 | 0 | 4 | 0 | 0 |
|
| ||||||
*Enterococcus faecalis.
†Enterococcus casseliflavus.
Genes detected by long-read next-generation sequencing that confer antimicrobial resistance (AMR) to macrolide–lincosamide–streptogramin (MLS).
| Isolate | AMR genes conferring MLS Resistance | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| EF01 |
|
|
|
|
|
|
| EF02 |
|
|
|
|
|
|
| EF03 |
|
|
|
|
|
|
| EF04 |
|
|
|
|
|
|
| EF05 |
|
|
|
|
|
|
| EF06 |
|
|
|
|
|
|
| EF07* |
|
|
|
|
|
|
| EF08 |
|
|
|
|
|
|
| EF09 |
|
|
|
|
|
|
| EF10 |
|
|
|
|
|
|
| EF11 |
|
|
|
|
|
|
| EF12 |
|
|
|
|
|
|
| EF13* |
|
|
|
|
|
|
| EF14 |
|
|
|
|
|
|
| EF15 |
|
|
|
|
|
|
| EF16* |
|
|
|
|
|
|
| EF17 |
|
|
|
|
|
|
| EF22 |
|
|
|
|
|
|
| EF23† |
|
|
|
|
|
|
|
| 8 | 16 | 1 | 3 | 1 | 1 |
|
| ||||||
*Enterococcus faecalis.
†Enterococcus casseliflavus.